IDEXX Enterolert-DW Obtains the First AFNOR NF VALIDATION for Detection of Enterococci in Drinking Water

IDEXX Enterolert-DW Obtains the First AFNOR NF VALIDATION for Detection of Enterococci in Drinking Water

November 01, 2013

IDEXX announces that the Association Française de Normalisation (AFNOR) has just granted NF Validation to the method Enterolert®-DW and Quanti-Tray® for the detection of enterococci in drinking water (Certificate Number IDX 33/03-10/13). This new validation makes Enterolert-DW the first and only method validated by AFNOR for the detection of enterococci bacteria in drinking water.

The certification for Enterolert-DW and Quanti-Tray was granted under the NF validation scheme for water microbiological analysis.

The validation is the result of an independent study in which a total of 12 laboratories participated.

This extensive study, which was evaluated by an independent panel of experts, demonstrated Enterolert-DW to be equivalent to the official method of testing for enterococci bacteria in drinking water. In addition, the data generated will also facilitate the accreditation of laboratories using this methodology.

The Enterolert-DW/Quanti-Tray method provides quantitative, confirmed results for the detection of enterococci in drinking water samples within 24 hours.

AFNOR has previously validated the Colilert-18®/Quanti-Tray® method from IDEXX as the first

method for the testing of both drinking water and bathing water for coliform bacteria and E.coli.

Quality control of Milk and Dairy products from Metrohm!

Quality control of Milk and Dairy products from Metrohm!

The analysis of milk and dairy products requires error-prone and time-consuming sample preparation techniques. Our automated instruments take over sample preparation. Besides saving time and improving traceability, you can increase the reliability of your analyses and ensure compliance with international regulations.

September 24, 2018 More +
Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Multiplicom is proud to launch Clarigo™, a new CE-IVD1 non-invasive prenatal test (NIPT). This highly accurate blood test will enable genetic analysis laboratories to detect the presence or absence of major chromosomal abnormalities such as trisomy 21 (Down’s syndrome), 18 (Edwards’ syndrome) and 13 (Patau syndrome), in the fetus, as early as in the first trimester of pregnancy by analysis of the fetus’s DNA in the maternal blood.

October 22, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us